Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth M Messmer

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
The Ocular Surface|April 22, 2023
TFOS Lifestyle: Impact of elective medications and procedures on the ocular surfaceJosé Alvaro P Gomes, Dimitri T Azar, Christophe Baudouin, et al.
The Ocular Surface|June 11, 2023
Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatmentMiriam Kolko, Gus Gazzard, Christophe Baudouin, et al.
Archives of Dermatology|June 20, 2002
Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old ageBerthold Rzany, Karin Partscht, Martin Jung, et al.
Cornea|December 14, 2011
Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHDTina Dietrich-Ntoukas, Claus Cursiefen, Henrike Westekemper, et al.
The Ocular Surface|June 7, 2020
TFOS European Ambassador meeting: Unmet needs and future scientific and clinical solutions for ocular surface diseasesSusan Erickson, Amy Gallant Sullivan, Stefano Barabino, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
The Ocular Surface|April 22, 2023
TFOS Lifestyle: Impact of elective medications and procedures on the ocular surfaceJosé Alvaro P Gomes, Dimitri T Azar, Christophe Baudouin, et al.
The Ocular Surface|June 11, 2023
Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatmentMiriam Kolko, Gus Gazzard, Christophe Baudouin, et al.
Archives of Dermatology|June 20, 2002
Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old ageBerthold Rzany, Karin Partscht, Martin Jung, et al.
Cornea|December 14, 2011
Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHDTina Dietrich-Ntoukas, Claus Cursiefen, Henrike Westekemper, et al.
The Ocular Surface|June 7, 2020
TFOS European Ambassador meeting: Unmet needs and future scientific and clinical solutions for ocular surface diseasesSusan Erickson, Amy Gallant Sullivan, Stefano Barabino, et al.
Pageof 9